› Forums › General Melanoma Community › Results::Phase III study of the combination of Tafinlar® (dabrafenib)/Mekinist® (trametinib)
- This topic has 6 replies, 2 voices, and was last updated 10 years, 10 months ago by bj63.
- Post
-
- January 24, 2014 at 8:19 pm
GSK announces headline results for Phase III study of the combination of Tafinlar® (dabrafenib) and Mekinist® (trametinib) in metastatic melanoma
Issued: Friday 24 January 2014, London UK – LSE Announcement
- Replies
-
-
- January 25, 2014 at 8:31 pm
Thanks for posting this Jerry. I am going to Mayo Clinic in Rochester on Tuesday and hope to start using this combination. So far, IPI and Zelboraf have failed for me so this is HUGE in terms of timing! The combination was just approved on January 10 as Phase 1 and 2 trials have been promising. Really hoping they're on to something here! Thanks again…
-
- January 25, 2014 at 8:31 pm
Thanks for posting this Jerry. I am going to Mayo Clinic in Rochester on Tuesday and hope to start using this combination. So far, IPI and Zelboraf have failed for me so this is HUGE in terms of timing! The combination was just approved on January 10 as Phase 1 and 2 trials have been promising. Really hoping they're on to something here! Thanks again…
-
- January 25, 2014 at 8:31 pm
Thanks for posting this Jerry. I am going to Mayo Clinic in Rochester on Tuesday and hope to start using this combination. So far, IPI and Zelboraf have failed for me so this is HUGE in terms of timing! The combination was just approved on January 10 as Phase 1 and 2 trials have been promising. Really hoping they're on to something here! Thanks again…
-
- You must be logged in to reply to this topic.